Search results
Novo Nordisk earnings are coming during a weight loss drugs sales surge. Here are 3 things to watch
Quartz· 6 days agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy,...
Richard Schillig: Reminder of another hidden tax we almost forgot about
Quad-City Times· 2 days agoToday I want to remind all Medicare persons about a kind of hidden tax that still exists and we...
What if I can't find a doctor? Physician shortage will change how Americans receive care.
USA Today· 6 days agoA whopping 83 million Americans don't have sufficient access to a primary care provider. Within a...
‘The right people:’ Florida man gets free financial lifeline he never knew existed
WKMG ClickOrlando· 6 days agoDonnie Graham, a 77-year-old Florida retiree on a fixed income, found himself in need of a place to...
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity...
Benzinga· 7 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 3 days agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
'Miracle' weight-loss drugs could have reduced health disparities. Instead they got worse
The Day· 5 days agoThe American Heart Association calls them "game changers." Oprah Winfrey says they're "a gift." Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. Obesity ...
CVS reports $1.1B income in Q1, cuts earnings guidance
Becker’s Hospital Review· 6 days agoCVS Health cut its earnings guidance for 2024 based on rising medical costs. CVS Health reported $1.1 billion in net income in the first quarter of 2024, according to its latest earnings documents ...
Earnings call: GSK forecasts growth with strong Q1 performance
Investing.com· 3 days agoGSK (GSK) reported robust earnings for the first quarter, with a 13% increase in sales to £7.4...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 3 days agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...